
Sentillion
Population Health Management & Healthcare Analytics | Caradigm.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | Acquisition | ||
Total Funding | 000k |






Related Content
Inspirata, Inc. operates as a global healthcare informatics company, providing oncology-focused software solutions. Founded in 2014 by Satish K. Sanan, the firm is headquartered in Tampa, Florida. Sanan, a serial entrepreneur who founded IMRglobal in 1988, was motivated to impact cancer care after losing family members to the disease, leveraging his technology background to form Inspirata.
The company's business model centers on developing and deploying comprehensive cancer informatics solutions that integrate disparate data sources from the entire cancer care journey. Its clients are primarily cancer centers, healthcare institutions, research organizations, and pharmaceutical companies in North America and Europe. Inspirata generates revenue through its software and services, which aim to streamline workflows, improve diagnostic accuracy, and facilitate research. The company’s offerings are built upon a proprietary Natural Language Processing (NLP) engine, refined over two decades, which structures and analyzes unstructured patient data from various clinical reports.
Inspirata’s product suite includes solutions for automated cancer registry, clinical trial matching, and digital pathology. Its E-Path Plus software provides automated casefinding and data abstraction for cancer registries. The Trial Navigator suite uses the NLP engine to match patients with suitable clinical trials in real-time. A key strategic move was the 2018 acquisition of Caradigm, a health analytics company, from GE Healthcare. This acquisition was aimed at leveraging Caradigm's big data platform to accelerate the development of Inspirata's Cancer Information Data Trust (CIDT), a project designed to provide new insights for clinicians and researchers. In December 2022, Fujifilm acquired Inspirata's Dynamyx® digital pathology business, a strategic transaction allowing Inspirata to focus on its AI and NLP-driven oncology informatics solutions.
Keywords: oncology informatics, cancer registry automation, clinical trial matching, natural language processing, healthcare data analytics, digital pathology, cancer diagnostics, population health management, healthcare IT, cancer informatics, cancer care continuum, pathology workflow, patient data management, structured data, unstructured data analysis, clinical decision support, healthcare software solutions, medical informatics, cancer research technology, survivorship improvement